MEK1-RSK2 contributes to Hedgehog signaling by stabilizing GLI2 transcription factor and inhibiting ubiquitination

Z Liu1, T Li2, M I Reinhold3

  • 11] Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA [2] Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Oncogene
|December 5, 2012
PubMed

Insights

The MEK-RSK pathway stabilizes GLI2 protein by inhibiting GSK-3β-mediated degradation, offering a new therapeutic target for multiple myeloma by enhancing GLI2 levels.

Area of Science:

  • Molecular Biology
  • Oncology
  • Signal Transduction

Background:

  • GLI2 is a key transcription factor in Hedgehog signaling, crucial for tumorigenesis in various human cancers.
  • Mechanisms regulating GLI2 protein expression and stability remain incompletely understood, hindering targeted therapeutic development.

Purpose of the Study:

  • To elucidate the regulatory mechanisms controlling GLI2 protein stability.
  • To investigate the role of the MEK-ERK-RSK signaling pathway in GLI2 regulation.
  • To explore the therapeutic potential of targeting the MEK-RSK pathway in multiple myeloma.

Main Methods:

  • Investigated GLI2 modulation by MEK1 at mRNA and protein levels.
  • Assessed the impact of MEK1 and RSK2 on GLI2 half-life, nuclear translocation, and ubiquitination.
  • Utilized GLI2 mutants lacking GSK-3β phosphorylation sites to determine MEK-RSK's mechanism of action.
  • Compared GLI2 protein levels in multiple myeloma cells versus normal B cells.
  • Evaluated the synergistic effect of RSK and GLI inhibitors on multiple myeloma cell apoptosis.

Main Results:

  • Mitogen-activated protein kinase kinase 1 (MEK1) stabilizes GLI2 protein by prolonging its half-life and enhancing nuclear translocation.
  • RSK2, downstream of MEK-ERK, mimics MEK1's effect on GLI2 stabilization.
  • MEK-RSK pathway stabilizes GLI2 by inhibiting glycogen synthase kinase-3 beta (GSK-3β)-dependent phosphorylation and subsequent ubiquitination.
  • Activated MEK-RSK signaling correlates with elevated GLI2 protein levels in multiple myeloma cells.
  • Combined inhibition of RSK and GLI significantly enhances apoptosis in multiple myeloma cells.

Conclusions:

  • The MEK-RSK signaling cascade positively regulates GLI2 protein stability by inhibiting its degradation.
  • This pathway functions by suppressing GSK-3β-mediated phosphorylation and ubiquitination of GLI2.
  • Targeting the MEK-RSK pathway presents a promising therapeutic strategy for multiple myeloma, potentially by sensitizing cells to GLI inhibitors.

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...